bioXXmed AG (FRA:T5O) Institutional Ownership: 0.04% (As of Aug. 30, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:T5O bioXXmed AG FRA:T5O
45 GF Score
Price €0.95
GF Value €10.54
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is bioXXmed AG Institutional Ownership?

bioXXmed AG FRA:T5O 45 Institutional Ownership is 0.04% as of Aug. 30, 2026. GuruFocus rates FRA:T5O with a GF Score™ of 45/100 and a GF Value™ of €10.54 (Possible Value Trap). The stock has 3 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, bioXXmed AG's institutional ownership is 0.04%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, bioXXmed AG's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, bioXXmed AG's Float Percentage Of Total Shares Outstanding is 0.00%.

bioXXmed AG Institutional Ownership Historical Data

* Premium members only.

The historical data trend for bioXXmed AG's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

bioXXmed AG Institutional Ownership Chart

bioXXmed AG Historical Data

The historical data trend for bioXXmed AG can be seen below:

2024-04-30 2024-05-31 2024-06-30 2024-07-31 2024-08-31 2024-09-30 2024-10-31 2024-11-30 2024-12-31 2025-01-31
Institutional Ownership 0.12 0.12 0.12 0.12 0.10 0.10 0.10 0.04 0.04 0.04
FRA:T5O
45GF Score
bioXXmed AG FRA:T5O
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

bioXXmed AG Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 0.04% mean?
bioXXmed AG (FRA:T5O) has a Institutional Ownership of 0.04% as of Aug. 30, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on bioXXmed AG and its competitors.
Is bioXXmed AG's Institutional Ownership too high?
bioXXmed AG's current Institutional Ownership is 0.04%. Overall, bioXXmed AG has a GF Score™ of 45/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does bioXXmed AG's Institutional Ownership compare to VRTX and REGN?
bioXXmed AG's Institutional Ownership of 0.04% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on bioXXmed AG and its competitors. bioXXmed AG's current Institutional Ownership is 0.04%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is bioXXmed AG stock overvalued right now?
Based on GuruFocus' analysis, bioXXmed AG (FRA:T5O) is currently considered Possible Value Trap. The stock's GF Value™ is €10.54, compared to a current price of €0.95 — trading 91% below its estimated fair value. The current Institutional Ownership is 0.04%. bioXXmed AG's overall GF Score™ is 45/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For bioXXmed AG (FRA:T5O), the current Institutional Ownership is 0.04% as of Aug. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is bioXXmed AG (FRA:T5O) Overvalued in 2026?

Based on GuruFocus' analysis, bioXXmed AG stock appears to be undervalued. The current stock price of €0.95 is trading 91% below its estimated GF Value™ of €10.54. GuruFocus considers bioXXmed AG to be Possible Value Trap.

Key valuation signals for FRA:T5O:

  • Institutional Ownership: 0.04%
  • GF Value™: €10.54 vs. price of €0.95 (91% below fair value)
  • GF Score™: 45/100 with 3 warning signs

No single metric tells the full story. See the FRA:T5O stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

bioXXmed AG Business Description

Other Exchanges T5O:Germany
Address Riedstrasse 2, Darmstadt, HE, DEU, 64295
bioXXmed AG is an investment and holding company in the technology sector. It originated from CytoTools GmbH, a successful German technology enterprise from the pharmaceuticals and medical products field.
45GF Score

Get the complete analysis for FRA:T5O

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.95
Price
€10.54
GF Value